Management of von Willebrand disease. Recommendations of the Hemostasis Group of the Polish Society of Hematology and Transfusiology (2022)

  • Zdziarska J
  • Chojnowski K
  • Klukowska A
  • et al.
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Recommendations of the Group on Hemostasis of the Polish Society of Hematology and Transfusiology are an update of the guidelines issued in 2008 [1]. In the absence of adequately designed randomized clinical trials for the diagnosis and treatment of von Willebrand disease, these recommendations are largely based on retrospective studies, expert opinions, series of case reports as well as guidelines published in other countries. In questionable cases, most conclusive for the final diagnosis of von Willebrand disease (VWD) is the physician’s experience and his assessment of the patient’s clinical picture.

Cite

CITATION STYLE

APA

Zdziarska, J., Chojnowski, K., Klukowska, A., Łaguna, P., Łętowska, M., Mital, A., … Podolak-Dawidziak, M. (2022). Management of von Willebrand disease. Recommendations of the Hemostasis Group of the Polish Society of Hematology and Transfusiology (2022). Journal of Transfusion Medicine, 15(2), 75–99. https://doi.org/10.5603/jtm.2022.0009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free